SCHEMBL7653373

SCHEMBL7653373

OCCc1nc2cc(-c3nc4cc(-c5nc6cc(-c7ccccc7)ccc6[nH]5)ccc4[nH]3)ccc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAG1 P54619 2/20 0.48
PRKAA2 P54646 2/20 0.48
PRKAB1 Q9Y478 2/20 0.48
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
GAA P10253 1/20 0.45
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CHEK2 O96017 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
MMP8 P22894 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MMP13 P45452 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7660194 0.89 NPC1 (0.47) PRKAG1PRKAA2PRKAB1NPC1RAB9A
SCHEMBL7658619 0.87 RAB9A (0.46) PRKAG1PRKAA2PRKAB1NPC1RAB9A
SCHEMBL7649789 0.84 NPC1 (0.43) PRKAG1PRKAA2PRKAB1NPC1RAB9A
SCHEMBL24684964 0.83 CYP2C9 (0.52) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL14665682 0.82 RAD52 (0.55) PRKAG1PRKAA2PRKAB1NPC1RAB9A
SCHEMBL7986375 0.81 HTT (0.63) PRKAG1PRKAA2PRKAB1GAAKDM4E
SCHEMBL22649095 0.81 NPC1 (0.67) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL2688616 0.80 NPC1 (0.53) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7654167 0.79 NPC1 (0.51) NPC1RAB9AGAAKDM4EALDH1A1
Hydrochloric Acid SCHEMBL30033770 0.78 RAD52 (0.49) PRKAG1PRKAA2PRKAB1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9056887-B2 Minor groove binder phosphoramidites and methods of use ELITECH HOLDING B.V. (NL) 2015-06-16 US disclosed
US-20130030166-A1 MINOR GROOVE BINDER PHOSPHORAMIDITES AND METHODS OF USE ELITECH HOLDING B.V. 2013-01-31 US disclosed
US-6399642-B2 TRIS BENZIMIDAZOLES; FUNGICIDES, ANTICARCINOGENIC AGENTS, ENZYME INHIBITOR RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-06-04 US disclosed
US-20010009919-A1 Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-07-26 US disclosed
US-6221892-B1 Heterocyclic topoisomerase poisons THE STATE OF UNIVERSITY OF NEW JERSEY, RUTGERS 2001-04-24 US disclosed
EP-1054870-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-11-29 EP disclosed
US-6063801-A Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-05-16 US disclosed
WO-1999041241-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130030166-A1 MINOR GROOVE BINDER PHOSPHORAMIDITES AND METHODS OF USE PCNA, CD2BP2, BPGM PRKAG1 3073/4885PRKAA2 3171/4885PRKAB1 4054/4885
US-20010009919-A1 Heterocyclic topoisomerase poisons TOP1, TOP2A, TOP2B PRKAG1 795/4885PRKAA2 2262/4885PRKAB1 954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.